Acute exacerbations of COPD: The challenge is early treatment

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 2, 2009, Pages 79-81

  Seemungal, Terence A R ^a   Wedzicha, Jadwiga A ^b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

COPD; Exacerbation; Health burden; Hospitalisation

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EARLY INTERVENTION; EDITORIAL; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; PRIORITY JOURNAL; ACUTE DISEASE; DYSPNEA; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; NOTE; TIME;

ACUTE DISEASE; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; HOSPITALIZATION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS;

EID: 67650757466     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550902806011     Document Type: Editorial

References (28)

1. National Heart, Lung, and Blood Institute. Chronic obstructive pulmonary disease. Bethesda, MD: National Heart, Lung, and Blood Institute; 2006. Available from: http://www.nhlbi.nih.gov/ health/public/lung/other/copd fact.pdf (accessed January 15th, 2009).
2. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. ProcAmThorac Soc 2007; 4:502-506.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349(9064):1498-1504
4. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic Obstructive Pulmonary Disease Surveillance - United States, 1971-2000. MMWR 2002; 51(SS-6):1-16.
5. Johnston AK, Mannino DM. Epidemiology of COPD exacerbations. In Wedzicha JA, Martinez F (Eds.). Exacerbations Of Chronic Obstructive Pulmonary Disease (COPD). New York: Informa Healthcare USA 2009; 228:15-24.
6. Nurmagambetov T, Atherly A, Williams S, Holguin F, Mannino DM, Redd SC. What is the cost to employers of direct medical care for chronic obstructive pulmonary disease? COPD 2006; 3:203-209
7. Traver, GA. Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease. Heart Lung 1988; 17:689-697.
8. Osman LM, Godden DJ, Friend JAR, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52:67-71.
9. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Herńandez C, Alonso A, del Pozo F, de Toledo P, Antó JM, Rodríguez- Roisín R, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006; 28:123-130.
10. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356(8):775-789
11. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 Oct 9; 359(15):1543-1554
12. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608-1618.
13. Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2004; 169:1298-1303.
14. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008; 177(4):396-401. (Pubitemid 351317582)
15. Chandra D, Tsai, C, Camargo C. Acute Exacerbations of COPD: Delay in Presentation and the Risk of Hospitalization. COPD 2009.
16. Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur. Respir. J. 2008; 32:53-60.
17. Rowe BH, Cydulka RK, Tsai CL, Clark S, Sinclair D, Camargo CA Jr. Comparison of Canadian versus United States emergency department visits for chronic obstructive pulmonary disease exacerbation. Can Respir J. 2008; 15(6):295-301.
18. GOLD. Executive Summary: Global Strategy for the Diagnosis, Management, and Prevention of COPD. Updated 2007; available at: http://www.goldcopd.com/ Guidelineitem.asp?11=2&l2=1 &intId=989.
19. Radeos MS, Rowe BH, Clark S, Barr RG, Camargo CA Jr. Validation of self-reported COPD among patients in the emergency department. Am J Emerg Med Accepted 29th Jan 2008:In press.
20. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008; 177(1):19-26.
21. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S27-72.
22. BTS guidelines for the management of community acquired pneumonia: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20 Information/ Pneumonia/Guidelines/MACAPrevisedApr04.pdf.
23. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: Suppl. 2, 398S-401S.
24. Hurst JR, Donaldson GC, Perera WR,Wilkinson TM, Bilello JA, HaganGW, Vessey RS,Wedzicha JA. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 174(8):867-874
25. Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM; British Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit. UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006; 61(10):837-842
26. Soler-Cataluña JJ, Martínez-García MA, Roḿan Śanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
27. Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai- Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 Dec 12. [Epub ahead of print]
28. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupŕe A, B́egin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP; Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sant́e duQúebec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-591